EQS-News: Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025
Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025 ...
PharmiWeb2d
Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025
ConferenceHeidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025 26.03.2025 / 09:23 CET/CESTThe issuer is solely responsible for the content of this ...
FEPI: Mag7 Exposure With A 30% Yield
FEPI offers a 30% dividend yield using a covered call strategy on top tech stocks. See why FEPI ETF is suitable for ...
LyondellBasell: One Of The Best Times To Buy
LyondellBasell Industries is at a cyclical low but poised for recovery. Read why LYB stock's earnings rebound and high yield ...
ZyVersa Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
Phase 2a proof-of concept clinical trial for Cholesterol Efflux Mediator VAR 200 in patients with diabetic kidney disease (DKD) expected to begin H1-2025. Regulatory path for VAR 200's ...
Investopedia5d
The Difference Between Induced Consumption and Autonomous Consumption
Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Ebony Howard is a certified public ...